Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00234910
Status:
COMPLETED
Last Update Posted:
2008-07-10
First Post:
2005-09-13
Brief Title:
Efficacy of Simplified Two Drug Kaletra Regimen vs Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients
Sponsor:
Abbott
Organization:
Abbott
Study Overview
Official Title:
A Phase III Open Label Randomized Comparative Study of the Antiviral Efficacy of ARV Therapy With LopinavirRitonavir LPVr-Kaletra in Combination With Tenofovir TDF Versus Standard of Care Kaletra in Combination With 2 Nucleoside RTIs in naïve-HIV-1 Positive Patients
Status:
COMPLETED
Status Verified Date:
2008-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
KALEAD
Brief Summary:
The purpose of this study is to obtain a preliminary assessment of the antiviral activity and tolerability of simplified Kaletra dual agent therapy as initial treatment for HIV infection relative to a Kaletra three drug standard of care reference arm
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EUDRACT 2004-000786-35 | None | None | None |
| KALEAD | None | None | None |